SCHEMBL6175503

SCHEMBL6175503

Cc1cnccc1CC1(C)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 16/20 0.48
AR P10275 3/20 0.38
NTRK1 P04629 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL17558453 0.95 IGF1R (0.44) IGF1RAR
SCHEMBL6174374 0.90 IGF1R (0.48) IGF1RARNTRK1
SCHEMBL6174069 0.90 IGF1R (0.48) IGF1RAR
SCHEMBL6172562 0.89 IGF1R (0.47) IGF1RAR
SCHEMBL6173545 0.88 IGF1R (0.46) IGF1RARNTRK1
SCHEMBL6169482 0.86 IGF1R (0.45) IGF1RARNTRK1
SCHEMBL6173157 0.85 IGF1R (0.45) IGF1RAR
SCHEMBL6173987 0.85 IGF1R (0.45) IGF1RNTRK1
SCHEMBL6175510 0.84 IGF1R (0.45) IGF1RAR
SCHEMBL6173965 0.84 IGF1R (0.43) IGF1RARNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed